Avantor (AVTR) Cash from Financing Activities (2018 - 2026)
Avantor (AVTR) recorded quarterly Cash from Financing Activities of -$107.2 million in Q1 2026, down 15414.29% quarter-over-quarter from $700000.0 in Q4 2025, and down 219.05% on a YoY basis from $90.0 million in Q1 2025.
Avantor (AVTR) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Avantor's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$107.2 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 219.05% year-over-year to -$107.2 million; the TTM figure through Mar 2026 stood at -$483.0 million (up 59.23% YoY), while the FY2025 annual figure was -$409.4 million, up 68.05% from the prior year.
- Cash from Financing Activities was -$107.2 million for Q1 2026 at Avantor, down from $700000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $700000.0 in Q4 2025 to a low of -$755.3 million in Q4 2024.
- Historically, Cash from Financing Activities has averaged -$193.5 million across 5 years, with a median of -$188.4 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities plunged 310.27% in 2024, then soared 100.09% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$81.6 million in 2022, then plunged by 125.61% to -$184.1 million in 2023, then slumped by 310.27% to -$755.3 million in 2024, then jumped by 100.09% to $700000.0 in 2025, then slumped by 15414.29% to -$107.2 million in 2026.
- The last three Cash from Financing Activities figures came in at -$107.2 million (Q1 2026), $700000.0 (Q4 2025), and -$369.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | -107.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.20 Mn |
| Mar 31, 2026 | -107.20 Mn |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | -369.60 Mn |
| Sep 30, 2025 | -369.60 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Mar 31, 2024 | -130.20 Mn |
| Mar 31, 2024 | -130.20 Mn |
| Dec 31, 2023 | -184.10 Mn |
| Dec 31, 2023 | -184.10 Mn |